During the past decade, RTI International conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 12 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RTI International" #1 sponsor was "NICHD Neonatal Research Network" with 42 trials, followed by "RTI International" with 9 trials sponsored, "Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program" with 2 trials sponsored, "Johns Hopkins Bloomberg School of Public Health" with 1 trials sponsored and "NICHD Global Network for Women's and Children's Health" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RTI International" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 36 trials as a collaborator, "National Center for Research Resources (NCRR)" with 27 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Centers for Disease Control and Prevention" with 3 trials as a collaborator and "National Eye Institute (NEI)" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "RTI International" are "Infant, Newborn" (31 trials), "Infant, Small for Gestational Age" (24 trials), "Infant, Premature" (22 trials), "Infant, Low Birth Weight" (19 trials) and "Bronchopulmonary Dysplasia (BPD)" (6 trials). Many other conditions were trialed in "RTI International" in a lesser frequency.

Most popular intervention types in "RTI International" are "Drug" (19 trials), "Procedure" (8 trials), "Behavioral" (6 trials), "Device" (5 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Hydrocortisone" (3 trials), "Hypothermia" (2 trials), "Inositol lower volume" (2 trials) and "Normothermic Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "RTI International" are 54 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 16 active trials in "RTI International". 1 are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 34 completed trials in RTI International, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in RTI International, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".